Cited by 195Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation

Open access

Marinigh, Ricarda, Lane, Deirdre A., Lip, Gregory Y.H.·2011·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2010.12.013

Open this paper in CoChat — free account Open PDF

Abstract

The prevalence of atrial fibrillation (AF) in end-stage renal failure is high, with an increased risk of stroke among these patients with AF compared with the AF population without severe renal impairment. Many trials have shown the net clinical benefit of oral anticoagulation therapy for primary and secondary prevention of stroke in patient populations with AF. However, current stroke risk stratification schemes are based on studies that have deliberately excluded patients with severe renal impairment. Indeed, there are no large randomized controlled trials that assess the real risk/benefit of full intensity anticoagulation in patients with severe renal impairment. Also, rates of major bleeding episodes in anticoagulated hemodialysis patients with AF are high. These data are influenced by the lack of appropriate monitoring, the difficulties in maintaining the international normalized ratio target (variable between the studies), and an inaccurate bleeding classification. Thus, the limited available data may be difficult to apply to such a heterogeneous patient population, characterized by both an increased risk of bleeding and a hypercoagulability state, as seen in the patient population with severe renal impairment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.12.013

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Clinical epidemiology of cardiovascular disease in chronic renal disease
Rn, F., Parfrey, P. S., & Sarnak, M. J. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,960

Show all 79 references

Research works printed but not linked: 2

2003, U.S. Renal Data System: USRDS 2002 Annual Data Report, Am J Kidney Dis, 41, S165
Lip, 2011, Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk, Europace, 13, 145, 10.1093/europace/euq427 · DOI

Sorted by citations

Items 101–195 of 195

Anticoagulantes orales no dependientes de la vitamina K para pacientes con fibrilación auricular e insuficiencia renal grave
Mahmood, M., & Lip, G. Y. H. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.03.023 · Cited by 13
Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration
Yanagisawa, S., Inden, Y., Fujii, A., Ando, M., Funabiki, J., Murase, Y., Takenaka, M., Otake, N., Ikai, Y., Sakamoto, Y., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.033 · Cited by 13
Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation
Székely, O., Borgi, M., & Lip, G. Y. H. (2019) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2019.1591368 · Cited by 12
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
Lahtela, H. M., Kiviniemi, T., Puurunen, M. K., Schlitt, A., Rubboli, A., Ylitalo, A., Valencia, J., Lip, G. Y. H., & Airaksinen, J. K. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128492 · Cited by 11
Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study
Broder, A. R., Mowrey, W. B., Kim, M., Murakhovskaya, I., Billett, H. H., Neugarten, J., Costenbader, K. H., & Putterman, C. (2015) · Rheumatology · doi:10.1093/rheumatology/kev423 · Cited by 11
Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin Therapy
Numao, Y., Suzuki, S. S., Arita, T., Yagi, N., Otsuka, T., Sagara, K., Semba, H., Sasaki, K., Kano, H., Matsuno, S., et al. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1217 · Cited by 11
Renal Dysfunction, CHADS 2 Score, and Adherence to the Anticoagulant Treatment in Nonvalvular Atrial Fibrillation
Sun, Y., Wang, Y., Jiang, J., Wang, L., & Hu, D. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615611250 · Cited by 11
Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation
He, W., Zhang, H., Zhu, W., & Xue, Z. (2019) · Medicine · doi:10.1097/md.0000000000017628 · Cited by 11
Stroke And Bleeding Risk Assessment: Where Are We Now?
Dzeshka, M. S., & Lip, G. Y. H. (2014) · PubMed Central · doi:10.4022/jafib.1042 · Cited by 11
Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety.
Deitelzweig, S. B. (2013) · Europe PMC (PubMed Central) · Cited by 10
Warfarin Usage in Patients With Atrial Fibrillation Undergoing Hemodialysis in Indonesian Population
Akbar, M. R., Febrianora, M., & Iqbal, M. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101104 · Cited by 11
The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients
Gui, Y.-Y., Zou, S., Yang, W., Gong, S., Cen, Z., Xie, Z., & Cui, K.-J. (2019) · Medicine · doi:10.1097/md.0000000000018205 · Cited by 10
Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.
Nakanishi, N., Kaikita, K., Ishii, M., Kuyama, N., Tabata, N., Ito, M., Yamanaga, K., Fujisue, K., Hoshiyama, T., Kanazawa, H., et al. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.02.004 · Cited by 10
Renal Function and Oral Anticoagulant Treatment of Incident non-valvular Atrial Fibrillation: A Retrospective Study
Ramagopalan, S. V., Stamp, E., Sammon, C., Besford, M., Carroll, R., Mehmud, F., & Alikhan, R. (2019) · Future Cardiology · doi:10.2217/fca-2019-0012 · Cited by 8
Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-Analyses
Kim, J. Y., Steingroever, J., Lee, K. H., Oh, J. S., Choi, M., Lee, J. M., Larkins, N., Schaefer, F. S., Hong, S. H., Jeong, G. H., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020394 · Cited by 9
Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
Stoica, M. C., Gáll, Z., Gliga, M. L., Caldararu, C. D., & Székely, O. (2021) · Medicina · doi:10.3390/medicina57050422 · Cited by 8
Neue orale Antikoagulanzien und Niereninsuffizienz
Bauersachs, R. M. (2012) · Der Internist · doi:10.1007/s00108-012-3146-y · Cited by 8
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
García-Fernández, A., Marín, F. R., Roldán, V., Galcerá-Jornet, E., Martı́nez, J. G., Valdés, M., Sogorb, F., & Lip, G. Y. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.167 · Cited by 8
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
Mahmood, M., & Lip, G. Y. H. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.05.015 · Cited by 7
Atrial Fibrillation in Patients with Chronic Kidney Disease
Kotalczyk, A., Ding, W. Y., Wong, C. F., Rao, A., Gupta, D., & Lip, G. Y. H. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.04.005 · Cited by 8
Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients
Molteni, M., Bo, M., Minno, G. D., Pasquale, G. D., Genovesi, S., Toni, D., & Verdecchia, P. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1660-6 · Cited by 7
Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source
Ntaios, G., Lip, G. Y. H., Lambrou, D., Michel, P., Perlepe, K., Eskandari, A., Nannoni, S., Sirimarco, G., Strambo, D., Vemmos, K. N., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.023281 · Cited by 7
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
Bhatia, H. S., Bailey, J., Ünlü, O., Hoffman, K., & Kim, R. J. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13811 · Cited by 6
Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease
Barcía, J. A. P., Raposeiras‐Roubín, S., Abu-Assi, E., Erquicia, P. D., Castro, A. L., Lestón, L. R., Míguez, J. O., Bermúdez, I. G., & Íñiguez, A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.03.018 · Cited by 7
A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE
Hess, C. N., Al‐Khatib, S. M., Granger, C. B., & Lópes, R. D. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.824181 · Cited by 6
Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular
Copete, J. P., Esteve‐Pastor, M. A., Roldán, V., Valdés, M., & Marín, F. R. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30011-5 · Cited by 7
Real‐world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairment
Mert, K. U., Mert, G. Ö., Başaran, Ö., Beton, O., Doğan, V., Tekinalp, M., Aykan, A. Ç., Kalaycıoğlu, E., Bolat, I., Taşar, O., et al. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12758 · Cited by 6
Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease.
Engelbertz, C. M., & Reinecke, H. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.445 · Cited by 6
Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation
Pujadas-Mestres, L., Escolar, G., Arellano‐Rodrigo, E., & Galan, A. M. (2013) · Drugs of today · doi:10.1358/dot.2013.49.7.1980498 · Cited by 5
Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin
Lau, Y. C., Xiong, Q., Lip, G. Y. H., & Blann, A. D. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1166516 · Cited by 5
Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: Perspectives on improving patient care
Alshoaibi, N., Harbi, M. A., Modaimegh, H., AlQubbany, A., Saif, S. A., Connolly, D. L., Kharabsheh, S. M., Fathy, M., Hegazy, Y., Tarcha, N., et al. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1878878 · Cited by 5
Use of Novel Oral Anticoagulants in Patients With Heart Failure
Shantsila, E., & Lip, G. Y. H. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0285-y · Cited by 4
Cardiac Radiosurgery for the Treatment of Atrial Fibrillation
Bhatt, N. S., Fogarty, T. J., & Maguire, P. (2016) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2016.65015 · Cited by 4
Stroke Prevention in Atrial Fibrillation
Szapáry, L. B. (2015) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/2/4/00132 · Cited by 4
Management of Atrial Fibrillation in Patients With Kidney Disease.
Lau, Y. C., & Lip, G. Y. H. (2014) · PubMed Central · doi:10.4022/jafib.989 · Cited by 4
Necessity of Antiaggregation and Anticoagulation and Its Prognostic Impact: A Cardiologist’s View
Hink, U., & Voigtländer, T. (2020) · Visceral Medicine · doi:10.1159/000509896 · Cited by 5
Product safety spillovers and market viability for biologic drugs
Romley, J. A., & Shih, T. M. (2016) · International Journal of Health Economics and Management · doi:10.1007/s10754-016-9208-2 · Cited by 4
Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
Młodawska, E., Łopatowska, P., Małyszko, J., Banach, M., Sobkowicz, B., Covic, A. C., & Tomaszuk−Kazberuk, A. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1877-y · Cited by 4
Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention
Voukalis, C., & Lip, G. Y. H. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.02.010 · Cited by 4
An Update on Antithrombotic Therapy in Atrial Fibrillation: The Role of Newer and Emergent Drugs
DEEDWANIA, P. C., & Huang, G. W. (2012) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0623 · Cited by 3
Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants
Wada, R., Shinohara, M., Nakanishi, R., Kinosihita, T., Yuzawa, H., & Ikeda, T. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12493 · Cited by 2
Radiofrequency Catheter Ablation for Atrial Fibrillation Patients on Hemodialysis (From the Kansai Plus Atrial Fibrillation Registry) ― Clinical Impact of Early Recurrence ―
Onishi, N., Kaitani, K., Nakagawa, Y., Kobori, A., Inoue, K., Kurotobi, T., Morishima, I., Matsui, Y., Yamaji, H., Nakazawa, Y., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0671 · Cited by 3
Increased Incident Ischemic Stroke Risk in Advanced Kidney Disease: A Large-Scale Real-World Data Study
Maeda, T., Nishi, T., Funakoshi, S., Tada, K., Tsuji, M., Satoh, A., Kawazoe, M., Yoshimura, C., & Arima, H. (2020) · American Journal of Nephrology · doi:10.1159/000509567 · Cited by 3
What Every Doctor Should Know about Drug Safety in Patients with Chronic Kidney Disease
Paparella, M., Martina, V., Rizzo, M. A., & Gallieni, M. A. (2015) · Contributions to nephrology · doi:10.1159/000365821 · Cited by 3
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation
DEEDWANIA, P. C., & Acharya, T. (2015) · Core evidence · doi:10.2147/ce.s61441 · Cited by 3
Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): Retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGF
Wu, D., Mansoor, G. A., Kempf, C., Schwalm, M.-S., & Chin, J. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12379 · Cited by 3
Balancing Efficacy and Bleeding Risk in the Prevention of Stroke Due to Atrial Fibrillation with Newer Oral Anticoagulants
Agarwal, M. B., Verma, S., Mahapatra, M., Tripathi, A. K., Bhave, A. A., Deshpande, A., Vora, A. M., Dalal, J. J., Shah, A., & Bichu, S. (2012) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-012-0167-6 · Cited by 3
Oral anticoagulation in chronic kidney disease: A huge challenge
Marín, F. R., & Roldán, V. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-05-0324 · Cited by 3
Verdades y controversias de la anticoagulación en fibrilación auricular no valvular
Gómez-Rosero, J. A., & Sierra-Vargas, E. C. (2019) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.07.006 · Cited by 3
Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
Petrov, V. I., Shatalova, O. V., Герасименко, А. С., & Gorbatenko, V. S. (2019) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-4-530-537 · Cited by 3
How effective is pharmacotherapy for stroke and what more is needed? A focus on atrial fibrillation
Kotalczyk, A., Potpara, T., & Lip, G. Y. H. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1921738 · Cited by 2
Asymptomatic Left Atrial Thrombus in a Dialysis‐Dependent Patient Free of Thrombogenic Abnormalities
Takeshita, K., Matsushita, T., & Murohara, T. (2014) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12201 · Cited by 2
Management of atrial fibrillation in specific patient populations
Szymański, F. M., Lip, G. Y. H., & Filipiak, K. J. (2015) · Kardiologia Polska · doi:10.5603/kp.a2015.0223 · Cited by 2
Vascular Access for Hemodialysis - Overview and Emphasis on Complications
Octavio, J. (2013) · InTech eBooks · doi:10.5772/53220 · Cited by 2
Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up
Zemlyanskaya, O. A., Станиславовна, К. Е., Dobrovolsky, A. B., & Панченко, Е. П. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789978-86 · Cited by 2
A Review of JACC Articles on the Topic of Heart Rhythm Disorders: 2011–2012
Editors, T. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.026 · Cited by 2
Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.09.026 · Cited by 2
Treatment appropriateness of direct oral anticoagulants in patients with atrial fibrillation for stroke prevention: A real-world prospective study
Pasebani, Y., Rafati, A., Dalouchi, S., Bahadori, M. J., Ghoshouni, H., Haghjoo, M., Fazelifar, A. F., Alizadeh‐Diz, A., Madadi, S., Kamali, F., et al. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-024-03773-8 · Cited by 1
Long-term comparative efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and chronic kidney disease: A nationwide observational study
Talmor‐Barkan, Y., Kornowski, R., Witberg, G., Skalsky, K., Kalka, I., Rossman, H., Segal, E., & Yacovzada, N. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.06.020 · Cited by 1
Transitions of Care in Anticoagulation Management for Patients with Atrial Fibrillation
Deitelzweig, S. B. (2012) · Hospital Practice · doi:10.3810/hp.2012.10.999 · Cited by 1
CARDIAC SURGERY Truly low and high thromboembolic risk – impact of risk scores in real life
Ciuruś, T., Sobczak, S., & Lelonek, M. (2014) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2014.41921 · Cited by 1
Non-vitamin K antagonist oral anticoagulants for heart diseases
Борисовна, К. Т., Popova, L. V., & Николаевич, Б. И. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017899120-127 · Cited by 1
Seguridad de los anticoagulantes orales en enfermedad renal crónica avanzada
Barrada, M. C. U., Trespalacios, J. M. B., Castro-Sánchez, S., & Arrieta-Bechara, J. C. (2021) · Acta Médica Colombiana · doi:10.36104/amc.2021.1945 · Cited by 1
Thrombosis and Coagulopathy
Raksin, P. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99512-6_25 · Cited by 1
We should pay more attention to renal function before initiation of warfarin therapy
Yamaguchi, T., & Takahashi, N. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.10.001 · Cited by 1
Oral anticoagulation treatment in atrial fibrillation - To bleed or not to bleed, that is the question
Wieloch, M. (2011) · Lund University Publications (Lund University) · Cited by 1
Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Heart Failure and Atrial Fibrillation: Does Concomitant Kidney Disease Change our Practice?
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.552 · Cited by 1
Patientenauswahl für die Implantation eines Vorhofohr-Okkluders in der Primär- und Sekundärprävention des kardioembolischen Schlaganfalls bei Vorhofflimmern
Israel, C. W., Ridjab, D. A., Tschishow, W. N., & Buddecke, J. (2013) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-013-0266-6
Bleeding risk with oral anticoagulation - new frontiers and new questions
Banerjee, A., Lane, D. A., & Lip, G. Y. H. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02716.x
Mild renal disease increases major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting
Kumar, A., & Flaker, G. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0790
CHALLENGES TO ADVANCING THE EVIDENCE BASE FOR NEPHROLOGY: THE TIME IS RIGHT FOR COLLABORATION
Watson, K., Zachariah, D., & Kalra, P. R. (2013) · Journal of Renal Care · doi:10.1111/j.1755-6686.2013.12044.x
Safe anticoagulation for patients with CKD—are we there yet?
Soliman, E. Z. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.244
To the Editor— Adding renal dysfunction to CHA2DS2-VASc improves stroke prediction postcatheter ablation
Lane, D. A., & Banerjee, A. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.10.022
Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function
Jones, M. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-02007
Practical approaches to the treatment of atrial fibrillation: focus on stroke prevention using oral anticoagulant drugs
Potpara, T., Licina, M. M., & Polovina, M. M. (2013) · Clinical Practice · doi:10.2217/cpr.13.7
Comment évaluer le risque ischémique et hémorragique cérébral dans la fibrillation atriale ? Place des approches morphologiques et biologiques
Cohen, A. A., & Heuzey, J. Y. L. (2014) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(14)71485-5
Chronic kidney disease: One step further in the refinement of risk stratification of atrial fibrillation and impact on the choice of anticoagulant
Providencia, R. A., Ferreira, M. J., & Gonçalves, L. M. M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.008
How Can We Avoid a Stroke Crisis in Europe
Andreotti, F., Camm, A. J., & Lobban, T. (2012)
Atrial fibrillation in chronic hemodialysis patients
Peres, L. A. B., Luiz, A. D. A., Espiga, M. C., & Spivakoski, C. S. (2012)
Anticoagulant therapy for stroke prevention in CKD patients
Nakajima, M., Watanabe, M., & Ando, Y. (2016) · Nosotchu · doi:10.3995/jstroke.10410
Stratificazione del rischio tromboembolico ed emorragico nei pazienti con fibrillazione atriale. Parte I: il rischio tromboembolico Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
Abate, S. A., Neri, O. S. F., & Abrignani, M. G. (2013)
The prothrombotic state in atrial fibrillation : observations on fibrin clot structure and the relationship to renal dysfunction
Lau, Y. C. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Systematic Review/Meta-analysis Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized Trials
Sardar, P., Chatterjee, S., Herzog, E., Nairooz, R. S., Mukherjee, D., & Halperin, J. L. (2014)
Anticoagulation for Atrial Fibrillation in Patients with End- Stage Kidney Disease
Tran, Q. B., Jebeili, B., Sud, K., & Bose, B. (2018) · InTech eBooks · doi:10.5772/intechopen.78022
Comparison of the Efficacy and Safety of Warfarin and Antiplatelet Therapy in Patients with Atrial Fibrillation and End-Stage Renal Disease
Han, D., Uhm, J., Park, J. T., Kim, T., Joung, B., Yoo, T., Pak, H., Kang, S., & Lee, M. (2019) · Korean Journal of Medicine · doi:10.3904/kjm.2019.94.2.191
Anticoagulation in Patients with Renal Insufficiency
Barsoum, R. S., Wanas, H., & Shehab, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-25782-8_9
Atrial Fibrillation and Renal Disease.
Berkowitsch, A., Wójcik, M., Zaltsberg, S., Pajitnev, D., Erkapic, D., Schmitt, J., Hamm, C. W., Kuniss, M., & Neumann, T. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.837
ANTICOAGULATION BEFORE AND AFTER CARDIOVERSION OR ABLATION. CHALLENGES, PROBLEMS AND MISTAKES
Česnauskaitė, A., Montrimas, A., Rinkūnienė, D., & Puodžiūkynas, A. (2021) · Health Sciences · doi:10.35988/sm-hs.2021.014
Use of DOAC in Patients with Kidney Disease
Vio, R., Proietti, R., & Calò, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-74462-5_7
A Review of JACC Journal Articles on the Topic of Interventional Cardiology: 2011–2012
Editors, T. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.004
ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: THE AXIS OF ROTATION BETWEEN THE POLES OF RISK
Kobalava, Z. D. K., & Анатольевич, Ш. А. (2018) · Eurasian heart journal · doi:10.38109/2225-1685-2018-2-64-82
Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure
Funaki, T., Saji, M., Terada, M., Takamisawa, I., Nanasato, M., Nagao, T., Ikeda, T., & Isobe, M. (2023) · Internal Medicine · doi:10.2169/internalmedicine.1778-23
Phenotype-Directed Clinically Driven Low-Dose Direct Oral Anticoagulant for Atrial Fibrillation
Kao, T., & Liao, P.-J. (2023) · Future Cardiology · doi:10.2217/fca-2022-0109
The influence of renal impairment and race on maintenance warfarin dosing in a multi-ethnic Southeast Asian population
Tan, O., Lau, Y. H., Chua, T. S. J., Hon, J. S., Loke, M., & Fam, J. M. (2024) · Proceedings of Singapore Healthcare · doi:10.1177/20101058241253458
Silent Culprit Revealed: Renal Infarction Unmasking Atrial Fibrillation
Upadhyay, M., Joshi, S., Munir, M., Akinpeloye, O., & Dawood, T. (2026) · Cureus · doi:10.7759/cureus.103934

Authors: Marinigh, R., Lane, D. A., & Lip, G. Y. H.
Affiliations: University of Trieste (IT)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Lane, Deirdre A.
Lip, Gregory Y.H.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2011-03
Volume: 57
Issue: 12
Pages: 1339-1348
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2010.12.013
OpenAlex: W2163399076
Cited by: 195
References: 79
Citations by year: 2026: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 13 · 2020: 7 · 2019: 12 · 2018: 11 · 2017: 12 · 2016: 18 · 2015: 18 · 2014: 25 · 2013: 35 · 2012: 25
FWCI: 4.98
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 905 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Bayer Healthcare
AstraZeneca
Boehringer
Bayer
Pfizer/BMS
Biotronic
Astellas
Sanofi
Cardiome
Merck
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, severe renal impairment, end-stage renal disease, stroke prevention, oral anticoagulation, hemodialysis, major bleeding, stroke risk stratification, INR monitoring, hypercoagulability
MeSH terms: Algorithms, Anticoagulants, Atrial Fibrillation, Renal Dialysis, Hemorrhage, Humans, Kidney Failure, Chronic, Thromboembolism, Comorbidity, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks